Burk Holdings’s GSK GSK Stock Holding History

Burk Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.33K	Hold	178	–	–	﹤0.01%	280
2026 Q1	$9.82K	Buy	+178	New	+$9.65K	﹤0.01%	270

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Burk Holdings's GSK Position: Q2 2026 in Review

Burk Holdings held its GSK (GSK) position steady in Q2 2026 at 178 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Burk Holdings first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.82K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Burk Holdings held 178 shares of GSK worth $9.33K as of Q2 2026.
Burk Holdings left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Burk Holdings's portfolio in Q2 2026, its #280 holding.
Burk Holdings first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
Burk Holdings's GSK position peaked at $9.82K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.